[Clinical effects of chemotherapy in combination with radiotherapy for advanced lung cancer.].
Ping Zhu
Abstract
Ping Zhu
Abstract
BACKGROUND: To study the curative effects by concomitant chemotherapy plus radiotherapy for advanced lung cancer. METHODS: FromJanuary 1992 to December 1994 , radiotherapy was given in 52 patients with advanced lung cancer after 2-4 cycles of chemotherapy. The radiation does ranged from 55-70 Gy/ 5. 5-7 weeks. RESULTS: The complete response (CR) rate was 13. 5 % , and partial response (PR) rate was 51. 9 %. The overall effective (CR + PR) rate was 65. 4 %. The median survival period was 15. 3 months. CONCLUSIONS: Combination of chemotherapy plus radiotherapy is preferable in treating advanced lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND: To study the curative effects by concomitant chemotherapy plus radiotherapy for advanced lung cancer. METHODS: FromJanuary 1992 to December 1994 , radiotherapy was given in 52 patients with advanced lung cancer after 2-4 cycles of chemotherapy. The radiation does ranged from 55-70 Gy/ 5. 5-7 weeks. RESULTS: The complete response (CR) rate was 13. 5 % , and partial response (PR) rate was 51. 9 %. The overall effective (CR + PR) rate was 65. 4 %. The median survival period was 15. 3 months. CONCLUSIONS: Combination of chemotherapy plus radiotherapy is preferable in treating advanced lung cancer.
Key concepts: Lung cancer, Radiation therapy, Medicine, Chemotherapy, Concomitant, Oncology, Internal medicine, Survival rate